Page last updated: 2024-10-22

alendronate and Injuries, Spinal

alendronate has been researched along with Injuries, Spinal in 2 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Research Excerpts

ExcerptRelevanceReference
"During the second year, the bone resorption marker, serum N-telopeptide, rose by 27% in the calcitriol group (P< or =0."2.72Discontinuing antiresorptive therapy one year after cardiac transplantation: effect on bone density and bone turnover. ( Addesso, V; Cohen, A; Mancini, D; Maybaum, S; McMahon, DJ; Namerow, P; Shane, E; Staron, RB, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, A1
Addesso, V1
McMahon, DJ1
Staron, RB1
Namerow, P1
Maybaum, S1
Mancini, D1
Shane, E1
Lems, WF1
Dijkmans, BA1

Reviews

1 review available for alendronate and Injuries, Spinal

ArticleYear
[Effect of anti-osteoporosis agents on the incidence of vertebral fractures].
    Nederlands tijdschrift voor geneeskunde, 2000, Oct-07, Volume: 144, Issue:41

    Topics: Alendronate; Bone Density; Calcitonin; Calcium Channel Blockers; Densitometry; Etidronic Acid; Femal

2000

Trials

1 trial available for alendronate and Injuries, Spinal

ArticleYear
Discontinuing antiresorptive therapy one year after cardiac transplantation: effect on bone density and bone turnover.
    Transplantation, 2006, Mar-15, Volume: 81, Issue:5

    Topics: Adult; Alendronate; Biomarkers; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone

2006